Molecular pathogenesis of malignant gliomas
BKA Rasheed, RN Wiltshire, SH Bigner… - Current opinion in …, 1999 - journals.lww.com
De novo glioblastomas develop in older patients without prior clinical history of less
malignant tumors. Progressive glioblastomas are common among younger patients and …
malignant tumors. Progressive glioblastomas are common among younger patients and …
Use of replicating oncolytic adenoviruses in combination therapy for cancer
RL Chu, DE Post, FR Khuri, EG Van Meir - Clinical Cancer Research, 2004 - AACR
Oncolytic virotherapy is the use of genetically engineered viruses that specifically target and
destroy tumor cells via their cytolytic replication cycle. Viral-mediated tumor destruction is …
destroy tumor cells via their cytolytic replication cycle. Viral-mediated tumor destruction is …
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
S Marino, M Vooijs, H Van Der Gulden… - Genes & …, 2000 - genesdev.cshlp.org
Medulloblastomas are among the most common malignancies in childhood, and they are
associated with substantial mortality and morbidity. The molecular pathogenesis as well as …
associated with substantial mortality and morbidity. The molecular pathogenesis as well as …
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
Purpose: Advances in brain tumor biology indicate that transfer of p53 is an alternative
therapy for human gliomas. Consequently, we undertook a phase I clinical trial of p53 gene …
therapy for human gliomas. Consequently, we undertook a phase I clinical trial of p53 gene …
Amplification and Overexpression of the MDM4 (MDMX) Gene from 1q32 in a Subset of Malignant Gliomas without TP53 Mutation or MDM2 Amplification
MJ Riemenschneider, R Büschges, M Wolter… - Cancer research, 1999 - AACR
We have previously reported on the amplification and overexpression of the MDM2 proto-
oncogene in a subset of malignant gliomas without TP53 mutation (G. Reifenberger et al …
oncogene in a subset of malignant gliomas without TP53 mutation (G. Reifenberger et al …
[图书][B] Brain Tumors E-Book: An Encyclopedic Approach
AH Kaye, ER Laws Jr - 2011 - books.google.com
Meet the increasing need for effective brain tumor management with the highly anticipated
revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past …
revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past …
Genetic and hypoxic regulation of angiogenesis in gliomas
Infiltrative astrocytic neoplasms are by far the most common malignant brain tumors in
adults. Clinically, they are highly problematic due to their widely invasive nature which …
adults. Clinically, they are highly problematic due to their widely invasive nature which …
p53 in neurodegenerative diseases and brain cancers
F Checler, CA da Costa - Pharmacology & therapeutics, 2014 - Elsevier
More than thirty years elapsed since a protein, not yet called p53 at the time, was detected to
bind SV40 during viral infection. Thousands of papers later, p53 evolved as the main tumor …
bind SV40 during viral infection. Thousands of papers later, p53 evolved as the main tumor …
[HTML][HTML] High prevalence of focal and multi-focal somatic genetic variants in the human brain
Somatic mutations during stem cell division are responsible for several cancers. In principle,
a similar process could occur during the intense cell proliferation accompanying human …
a similar process could occur during the intense cell proliferation accompanying human …
Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression
DJ Brat, TB Mapstone - Annals of internal medicine, 2003 - acpjournals.org
Malignant gliomas have invasive properties that make them nearly impossible to cure
surgically. Most physicians agree that the best hope for long-term control lies with adjunctive …
surgically. Most physicians agree that the best hope for long-term control lies with adjunctive …